Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic Strategies

by Monica Mossenta, Davide Busato, Michele Dal Bo, Giuseppe Toffoli
Published 2020-06-01

The Proteoglycan Glypican-1 as a Possible Candidate for Innovative Targeted Therapeutic Strategies for Pancreatic Ductal Adenocarcinoma

by Davide Busato, Monica Mossenta, Michele Dal Bo, Paolo Macor, Giuseppe Toffoli
Published 2022-09-01

Novel Nanotechnology Approaches to Overcome Drug Resistance in the Treatment of Hepatocellular Carcinoma: Glypican 3 as a Useful Target for Innovative Therapies

by Monica Mossenta, Davide Busato, Michele Dal Bo, Paolo Macor, Giuseppe Toffoli
Published 2022-09-01

A Novel Epigenetic Machine Learning Model to Define Risk of Progression for Hepatocellular Carcinoma Patients

by Luca Bedon, Michele Dal Bo, Monica Mossenta, Davide Busato, Giuseppe Toffoli, Maurizio Polano
Published 2021-01-01

New Insight into Therapies Targeting Angiogenesis in Hepatocellular Carcinoma

by Monica Mossenta, Davide Busato, Lorena Baboci, Federica Di Cintio, Giuseppe Toffoli, Michele Dal Bo
Published 2019-07-01

A novel complement-fixing IgM antibody targeting GPC1 as a useful immunotherapeutic strategy for the treatment of pancreatic ductal adenocarcinoma

by Davide Busato, Sara Capolla, Paolo Durigutto, Monica Mossenta, Sara Bozzer, Daniele Sblattero, Paolo Macor, Michele Dal Bo, Giuseppe Toffoli
Published 2023-11-01

Targeted chitosan nanobubbles as a strategy to down-regulate microRNA-17 into B-cell lymphoma models

by Sara Capolla, Monica Argenziano, Sara Bozzer, Tiziana D’Agaro, Tamara Bittolo, Luigina De Leo, Tarcisio Not, Davide Busato, Michele Dal Bo, Giuseppe Toffoli, Roberta Cavalli, Valter Gattei, Riccardo Bomben, Paolo Macor
Published 2023-06-01